PPD DEVELOPMENT, L.P. - Coronavirus Contracts

Contracts Vendors Agencies Categories States

Coronavirus Contracts

Tracking Federal Purchases to Fight the Coronavirus

Home › All Vendors › Vendor ›

PPD DEVELOPMENT, L.P.

Total Committed Value of Federal Contracts

$40.4M

Total Contracts

Total Actions

Location

Wilmington, NC

Recent Contract Actions

Contracts can have multiple “contract actions”: This is how agencies spend money for a specific purpose, adjust the amount committed or change the contract in a way that doesn’t affect the amount. That last scenario is usually indicated by a $0 action. If there is a contract action for a negative amount, it generally means the contract was adjusted or canceled.

Description	Category	Agency	Signed	Amount Committed
"COVID-19". TO PROVIDE A BROAD RANGE OF CLINICAL AND OTHER RELATED RESEARCH SUPPORT SERVICES FOR ACTIV2 CLINICAL TRIAL.	AIDS Research R&D (Basic Research)	National Institutes of Health	July 15, 2021	-$36,187,451
"COVID 19". TO PROVIDE A BROAD RANGE OF CLINICAL AND OTHER RELATED RESEARCH SUPPORT SERVICES FOR ACTIV2 CLINICAL TRIAL, AN OPERATION WARP SPEED PROJECT.	AIDS Research R&D (Basic Research)	National Institutes of Health	December 07, 2020	$8,872,517
"COVID -19": TO PROVIDE A BROAD RANGE OF CLINICAL AND OTHER RELATED RESEARCH SUPPORT SERVICES FOR ACTIV2 CLINICAL TRIAL, AN OPERATION WARP SPEED PROJECT.	AIDS Research R&D (Basic Research)	National Institutes of Health	December 04, 2020	-$8,872,517
ESTABLISHMENT OF HIGH THROUGHPUT SARS-COV-2 BINDING ANTIBODY IMMUNOASSAY CAPABILITY AND TESTING OF HUMAN SERUM SAMPLES	Biomedical Advanced Development R&D	Office of Assistant Secretary for Preparedness and Response - HHS	November 16, 2020	$2,750,095
SUPPORT NATIONWIDE ACCESS TO ANTI-MALARIAL DRUGS BY EMERGENCY USE AUTHORIZATION (EUA) FOR HOSPITALIZED, SYMPTOMATIC ADULT AND ADOLESCENT PATIENTS CONFIRMED WITH SARS-COV-2 INFECTION, THE VIRUS WHICH CAUSES COVID-19	Biomedical R&D	Office of Assistant Secretary for Preparedness and Response - HHS	August 25, 2020	$0
"COVID-19" TO PROVIDE A BROAD RANGE OF CLINICAL AND OTHER RELATED RESEARCH SUPPORT SERVICES FOR ACTIV2 CLINICAL TRIAL, AN OPERATION WARP SPEED PROJECT.	AIDS Research R&D (Basic Research)	National Institutes of Health	July 28, 2020	$68,805,594
"COVID-19". TO PROVIDE A BROAD RANGE OF CLINICAL AND OTHER RELATED RESEARCH SUPPORT SERVICES FOR ACTIV2 CLINICAL TRIAL, AN OPERATION WARP SPEED PROJECT.	AIDS Research R&D (Basic Research)	National Institutes of Health	July 10, 2020	$3,616,950
"COVID-19". TO PROVIDE A BROAD RANGE OF CLINICAL AND OTHER RELATED RESEARCH SUPPORT SERVICES FOR NIAID/DAIDS-SUPPORTED CLINICAL RESEARCH PORTFOLIO AND OTHER INFECTIOUS DISEASES THAT ARE OF RELEVANCE TO HIV INFECTION AND AT RISK POPULATIONS.	AIDS Research R&D (Basic Research)	National Institutes of Health	June 25, 2020	$627,769
SUPPORT NATIONWIDE ACCESS TO ANTI-MALARIAL DRUGS BY EMERGENCY USE AUTHORIZATION (EUA) FOR HOSPITALIZED, SYMPTOMATIC ADULT AND ADOLESCENT PATIENTS CONFIRMED WITH SARS-COV-2 INFECTION, THE VIRUS WHICH CAUSES COVID-19	Biomedical R&D	Office of Assistant Secretary for Preparedness and Response - HHS	April 24, 2020	$0
AN EXPANDED ACCESS TREATMENT PROTOCOL FOR HYDROCHLOROQUINE AND CHLOROQUINE IN PATIENTS WITH CORONAVIRUS DISEASE (COVID-19), POSITIVE FOR SARS-COV-2 VIRUS EXPOSURE, OR PRE-EXPOSURE AND POST-EXPOSURE PROPHYLAXIS	Biomedical R&D	Office of Assistant Secretary for Preparedness and Response - HHS	March 24, 2020	$750,000

See this vendor on usaspending.gov ›

About this data

This data comes from the Federal Procurement Data System, which includes all contracts worth $10,000 or more. We look at all contracts that are tagged with the procurement code for COVID-19 or otherwise started in 2020 and contain “COVID-19” in the description. Department of Defense contracting data is subject to a 90-day delay before it appears in the data.